Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Xylitol for Otitis Media With Effusion in Children
NCT02950311Phase 3Withdrawn
- Sponsor
- Duke University
- Start
- Nov 2017
- Primary completion
- Nov 2017
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of xylitol in otitis media with effusion (OME) (2 arms), sponsored by Duke University. Primary endpoint: Time to middle ear effusion resolution at 24 weeks. Planned start Nov 2017; status: withdrawn.
02
Drugs
xylitol
03
Conditions
otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT02950311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950311.